The Auto Channel
The Largest Independent Automotive Research Resource
The Largest Independent Automotive Research Resource
Official Website of the New Car Buyer

Cannondale Announces Financial Results For the Q3 of Fiscal Year 2001

    BETHEL, Conn., April 30 Cannondale Corporation today announced results for the third
quarter of fiscal 2001, the period ended March 31, 2001.

    For the three months ended March 31, 2001, net sales were $32,636,000
compared to $40,308,000 recorded for the same period last year.  Included in
the net sales amount is approximately $1.7 million in motorsports sales.  The
reduction in sales was due to dealers' cautious buying patterns relating to
the weakening economy, adverse weather conditions, and a delay in delivery of
bicycle accessories from vendors which affected shipments in March.  In
addition, net sales were negatively affected by approximately $1.2 million
relating to foreign exchange fluctuations.  The loss for the third quarter of
fiscal 2001, prior to the recognition of $2,287,000 to record a valuation
allowance for net deferred tax assets, was $3,064,000 compared to the loss of
$762,000 recorded during the same period last year.  Although the Company
expects to ultimately utilize its net deferred tax assets, a valuation
allowance was established in accordance with Statement of Financial Accounting
Standards No. 109.  The Company's bicycle business achieved pre-tax earnings
of $559,000 for the third quarter of fiscal 2001 compared to pre-tax earnings
of $2,021,000 for the third quarter of fiscal 2000.  The decrease in profits
is commensurate with the factors noted above.

    The loss per share for the third quarter of fiscal 2001 was 41 cents,
exclusive of the deferred tax asset valuation provision (30 cents per share),
compared to the loss per share of 10 cents recorded for the same period last
year.  The net loss per share for the third quarter of fiscal 2001 was
71 cents.

    For the nine months ended March 31, 2001, net sales were $104,010,000,
including approximately $3.2 million of motorsports shipments, compared to net
sales of $118,393,000 recorded for the same period last year.  The reduction
in sales was due to dealers' cautious buying patterns relating to the
weakening economy, adverse weather conditions, and a delay in delivery of
bicycle accessories from vendors which affected shipments in March.  In
addition, net sales were negatively affected by approximately $6.5 million
relating to foreign exchange fluctuations.  The loss for the first nine months
of fiscal 2001, prior to an extraordinary loss of $552,000 relating to the
write-off of deferred financing costs resulting from the early repayment of
approximately $12,000,000 of long-term debt, and the recognition of
$10,890,000 to record a valuation allowance for net deferred tax assets, as
noted above, was $6,107,000 compared to the loss of $1,593,000 recorded during
the prior-year period.  For the first nine months of fiscal 2001, the
Company's bicycle business produced pre-tax earnings of $4,548,000 compared to
the bicycle business pre-tax earnings of $3,892,000 for the same period last
year.  This increase in the bicycle business profit was attributable to the
increase in gross margin from 32.03% in the prior year to 32.40% in the
current year primarily due to more favorable product mix, coupled with reduced
selling, general and administrative expenses.

    The loss per share was 81 cents for the first nine months of fiscal 2001,
exclusive of the extraordinary loss (7 cents per share) and the deferred tax
asset valuation provision ($1.45 per share), compared to the net loss per
share of 21 cents recorded for the same period last year.  The net loss per
share for the first nine months of fiscal 2001 was $2.33.

    On April 27, 2001, Cannondale sold an aggregate of $4 million of
convertible subordinated debentures to two individual investors, including
Cannondale's Chairman, Chief Executive Officer and President, Joseph
Montgomery.  The $2 million debenture issued to Mr. Montgomery is due June 28,
2005 and is convertible into shares of Cannondale's common stock at an initial
conversion price of $4.50 per share.  The $2 million debenture issued to a
third party investor is due April 28, 2004 and is convertible into shares of
Cannondale's common stock at an initial conversion price of $3.75 per share.
Both debentures bear interest at an annual rate of 8%.  Cannondale intends to
use the net proceeds from the sale of the debentures for working capital
purposes.

    Prior year net sales and selling, general and administrative expenses have
been restated pursuant to EITF Issue 00-10, Accounting for Shipping and
Handling Fees and Costs.  In accordance with such, all shipping and handling
billings to customers have been included in net sales, and all freight costs
incurred for product shipments have been included in selling, general and
administrative expenses.  Previously, the Company offset shipping and handling
charges billed to customers and the related freight costs within selling,
general and administrative expenses.  For the quarterly periods ended
March 31, 2001 and April 1, 2000, shipping and handling billings of
approximately $373,000 and $442,000, respectively, have been included in net
sales.  For the nine months ended March 31, 2001 and April 1, 2000, shipping
and handling billings of approximately $1,186,000 and $1,368,000,
respectively, have been included in net sales.

    The third quarter also saw the official debut of the Cannondale FX400 ATV
(All-Terrain Vehicle), and its first test rides by editors from ATV magazines.
The reviews resulting from those test rides have appeared in recent weeks, and
they are exceedingly positive.

    "The FX400 is a thrilling addition to the sport quad market," was how ATV
Sport magazine's Glenn Hanson rated the new Cannondale.  "If (other ATV
manufacturers) want to compete on the high end of the high-performance market,
they better be working on something good or the FX400 will eat them alive."
Hansen's comments were echoed by Adam Campbell of 4-Wheel ATV Action magazine,
who dubbed the FX400 "the highest-tech quad ever developed."  Campbell added
that, "in a contest of all-out performance with the Cannondale, it looks like
Honda, Yamaha and Bombardier brought knives to a gun fight."

    Cannondale's bicycle division also debuted new designs during the third
quarter.  In March, the Company unveiled the downhill-specific Gemini and the
Scalpel, a lightweight, full-suspension model for cross-country racing.  The
Scalpel will be raced by the team's cross-country athletes, and Scalpel models
will also make their way into Cannondale dealerships for resale to consumers
in the coming months.

    Matt Phillips of Mountain Bike magazine was one of the first editors to
ride the Scalpel, and he was wowed by its technology.  After listing the
Scalpel's many innovative features, Phillips noted that "this complete full
suspension bike with tubeless tires and disc brakes weighs just 22 pounds.  I
shake my head and think, 'Who else but Cannondale?'"

    
                   CANNONDALE CORPORATION AND SUBSIDIARIES

                    Condensed Consolidated Balance Sheets
                      (In thousands, except share data)

                                                 March 31, 2001  July 1, 2000
                                                   (unaudited)

    Assets
    Current assets:
    Cash                                              $1,920         $5,064
    Trade accounts receivable, less allowances of
    $11,146 and $10,076                               47,833         50,224
    Inventories                                       42,861         40,413
    Deferred income taxes                                 --          5,571
    Prepaid expenses and other current assets          3,719          4,618
    Total current assets                              96,333        105,890
    Property, plant and equipment, net                36,352         40,114
    Other assets                                       5,703         18,903
    Total assets                                    $138,388       $164,907

    Liabilities and stockholders' equity
    Current liabilities:
    Accounts payable                                 $13,970        $15,912
    Revolving credit advances                          4,038          2,235
    Income taxes payable                                  27            307
    Warranty and other accrued expenses                8,742          7,403
    Current installments of long-term debt             4,856          4,577
    Total current liabilities                         31,633         30,434
    Long-term debt, less current installments         54,760         63,363
    Other noncurrent liabilities                         437            424
    Total liabilities                                 86,830         94,221
    Commitments and contingencies                         --             --

    Stockholders' equity:
    Common stock, $.01 par value:
    Authorized shares - 40,000,000
    Issued shares - 8,821,871 and 8,808,125               88             88
    Additional paid-in capital                        57,978         57,935
    Retained earnings                                 21,253         38,802
    Less 1,292,900 shares in treasury at cost       (20,162)       (20,162)
    Accumulated other comprehensive loss             (7,599)        (5,977)
    Total stockholders' equity                        51,558         70,686
    Total liabilities and stockholders' equity      $138,388       $164,907


                   CANNONDALE CORPORATION AND SUBSIDIARIES
               Condensed Consolidated Statements of Operations
                    (In thousands, except per share data)

                                  Third      Third        Nine        Nine
                                 Quarter    Quarter      Months      Months
                                 Fiscal      Fiscal      Fiscal      Fiscal
                                  2001        2000        2001        2000
                               (Unaudited) (Unaudited) (Unaudited) (Unaudited)

    Net sales                    $32,636     $40,308     $104,010  $118,393
    Cost of sales                 25,895      27,233       77,089    81,631
    Gross profit                   6,741      13,075       26,921    36,762

    Expenses:
    Selling, general and
     administrative                9,005      10,607       27,275    30,484
    Research and development       1,500       2,432        5,417     6,621
                                  10,505      13,039       32,692    37,105
    Operating income (loss)      (3,764)          36      (5,771)     (343)

    Other income (expense):
    Interest expense             (1,486)     (1,901)      (5,036)   (4,305)
    Other income (expense)         (199)         531          192     1,265
                                 (1,685)     (1,370)      (4,844)   (3,040)

    Pretax loss                  (5,449)     (1,334)     (10,615)   (3,383)

    Income tax benefit             2,385         572        4,508     1,790

    Loss before provision for
     deferred tax asset valuation
     and extraordinary item      (3,064)       (762)      (6,107)   (1,593)

    Deferred tax asset
     valuation provision         (2,287)          --     (10,890)        --

    Loss before
     extraordinary item          (5,351)       (762)     (16,997)   (1,593)

    Extraordinary loss,
     net of $0 tax benefit            --          --        (552)        --

    Net loss                    $(5,351)      $(762)    $(17,549)  $(1,593)


    Basic and diluted loss per
     share before
     extraordinary item          $(0.71)     $(0.10)      $(2.26)   $(0.21)

    Extraordinary loss per share      --          --       (0.07)        --

    Basic and diluted
     loss per share              $(0.71)     $(0.10)      $(2.33)   $(0.21)

    Weighted-average common
     shares outstanding            7,529       7,503        7,520     7,495